Concord Biotech, Vaibhav Gems Get Approval To Launch IPOs (Public Issue)
Concord is among the leading manufacturers of fermentation-based biopharmaceutical APIs focused on niche segments, such as immunosuppressant, oncology, anti-fungal and anti-bacterial.
from NDTV Profit-Latest https://ift.tt/zBbfjw4
Concord is among the leading manufacturers of fermentation-based biopharmaceutical APIs focused on niche segments, such as immunosuppressant, oncology, anti-fungal and anti-bacterial.
from NDTV Profit-Latest https://ift.tt/zBbfjw4
Concord is among the leading manufacturers of fermentation-based biopharmaceutical APIs focused on niche segments, such as immunosuppressant, oncology, anti-fungal and anti-bacterial.
Comments
Post a Comment